Novabone Graft

NovaBone Dental Putty

The next generation Calcium-Phosphosilicate bone substitute engineered for enhanced handling, osteostimulation, and predictable results. Pre-mixed, ready to use, and extremely user-friendly.

Login to View Pricing & Order
Excellent handling and adaptability
Supports faster clinical workflow
Excellent handling and adaptability
01

Clinical Snapshot

  • Primary Use Case: A synthetic, fully resorbable bone substitute that acts as a 3-dimensional porous scaffold to facilitate blood diffusion, revascularization, and sustain bone regeneration in oral surgical defects.
  • Ideal User: Implantologists, periodontists, oral surgeons, general dentists placing implants.
  • Procedure Compatibility: Crestal and lateral sinus lifts, socket preservation/extraction sites, immediate implants, periodontal/infrabony defects, ridge augmentation, partial extraction therapies, cystic cavities, and cranio-facial augmentation.
02

Key Benefits

Handling advantages: Pre-mixed, cohesive, moldable, and adaptable. Available in an industry-first uni-dose cartridge delivery system that simplifies dispensing in hard-to-reach areas.
Placement efficiency: Completely ready to use out of the package with zero mixing required.
Integration predictability: Features a bimodal particle size distribution—smaller particles provide an initial burst of Ca and P ions, while larger particles resist rapid resorption to sustain the bone regeneration process until replaced with living bone.
Surgeon confidence: 100% synthetic, fully resorbable, cleared by the US FDA, and has a proven "osteostimulative" effect (stimulating osteoblast proliferation).
Time-saving properties: Radiopaque (partially opaque on radiographs), stable at room temperature, and does not require refrigeration.

03

Clinical Differentiation

Patent protection: Features a unique, industry-first cartridge delivery system for bone grafts.
Unique formulation: Composed of 70% bioactive calcium phosphosilicate (CPS) particles combined with a water-soluble polyethylene glycol and glycerine binder.
Clinical acceptance: Cleared by the US FDA, distributed in over 40 countries, and supported by dozens of published clinical studies across multiple surgical applications.
Reliability in complex cases: Highly reliable in minimally invasive techniques and hard-to-access defects (e.g., gaps in immediate implant placement and crestal-approach sinus lifts).

04

Usage & Handling

Storage instructions: Highly stable at room temperature; does not require refrigeration.
Preparation steps: None required; ready to use immediately.
Clinical handling tips: For minimally invasive surgeries, use the NovaBone Cartridge System (cannula diameter is 2.8mm). Upon implantation, the water-soluble binder is absorbed within 24 to 72 hours, leaving the porous scaffold.
Shelf life: 4-year shelf-life.

06

Frequently Asked Questions

Clinical application: Can be used for sinus lifts, immediate implants, ridge augmentation, socket preservation, and treating periodontal defects.
Handling: How is it delivered? It can be dispensed via syringes, or the proprietary cartridge delivery system.
Compatibility: Cartridges must be used in conjunction with NovaBone’s specifically designed cartridge dispensers (Mini-Cart Dispenser or Jumbo Cartridge Dispenser).
Ordering: Available through a worldwide network of distributors. Formats may vary by country.

Link copied